Skip to main content

Filaggrin in Psoriasis

  • Chapter
  • First Online:
Filaggrin

Abstract

Psoriasis is a chronic inflammatory skin disease of multifactorial origin. A number of psoriasis susceptibility loci are known, and some are shared with susceptibility for atopic dermatitis. This has led to speculation that filaggrin gene (FLG) mutations and changes in filaggrin expression may also be associated with psoriasis.

Several studies have looked at this association, but none have so far demonstrated a correlation between psoriasis and the two major FLG variants R501X and 2282del4. However, in Asian individuals with psoriasis, studies have demonstrated an association between psoriasis and the P478S polymorphism of the FLG as well as the p.K4022X FLG mutation. Immunohistological studies have shown that filaggrin expression is downregulated in psoriatic skin compared to non-lesional skin. The precise mechanisms are unknown; however, it is possible that elevated levels of psoriasis-associated tumor necrosis factor-α and interleukin-17 may play a role in downregulating filaggrin expression in lesional psoriatic skin.

In summary, there is little evidence to support a correlation between FLG mutations and psoriasis except perhaps in Asian individuals. Available data indicate that the decreased filaggrin expression in lesional psoriatic skin is due to a secondary downregulation of filaggrin expression independent of genetic mechanisms.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Smith CH, Barker JN. Psoriasis and its management. BMJ. 2006;333(7564):380–4. Epub 2006/08/19.

    Article  PubMed Central  PubMed  Google Scholar 

  2. Huffmeier U, Traupe H, Oji V, Lascorz J, Stander M, Lohmann J, et al. Loss-of-function variants of the filaggrin gene are not major susceptibility factors for psoriasis vulgaris or psoriatic arthritis in German patients. J Invest Dermatol. 2007;127(6):1367–70. Epub 2007/01/27.

    Article  PubMed  Google Scholar 

  3. Proksch E, Brandner JM, Jensen JM. The skin: an indispensable barrier. Exp Dermatol. 2008;17(12):1063–72. Epub 2008/12/02.

    Article  PubMed  Google Scholar 

  4. Bowcock AM, Cookson WO. The genetics of psoriasis, psoriatic arthritis and atopic dermatitis. Hum Mol Genet. 2004;13(Spec No 1):R43–55. Epub 2004/03/05.

    Article  CAS  PubMed  Google Scholar 

  5. Brandrup F, Hauge M, Henningsen K, Eriksen B. Psoriasis in an unselected series of twins. Arch Dermatol. 1978;114(6):874–8. Epub 1978/06/01.

    Article  CAS  PubMed  Google Scholar 

  6. Lonnberg AS, Skov L, Skytthe A, Kyvik KO, Pedersen OB, Thomsen SF. Heritability of psoriasis in a large twin sample. Br J Dermatol. 2013;169:412–6.

    Article  CAS  PubMed  Google Scholar 

  7. Trembath RC, Clough RL, Rosbotham JL, Jones AB, Camp RD, Frodsham A, et al. Identification of a major susceptibility locus on chromosome 6p and evidence for further disease loci revealed by a two stage genome-wide search in psoriasis. Hum Mol Genet. 1997;6(5):813–20. Epub 1997/05/01.

    Article  CAS  PubMed  Google Scholar 

  8. Nair RP, Stuart PE, Nistor I, Hiremagalore R, Chia NV, Jenisch S, et al. Sequence and haplotype analysis supports HLA-C as the psoriasis susceptibility 1 gene. Am J Hum Genet. 2006;78(5):827–51. Epub 2006/04/28.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  9. Nair RP, Stuart P, Henseler T, Jenisch S, Chia NV, Westphal E, et al. Localization of psoriasis-susceptibility locus PSORS1 to a 60-kb interval telomeric to HLA-C. Am J Hum Genet. 2000;66(6):1833–44. Epub 2000/05/10.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  10. Elder JT, Nair RP, Henseler T, Jenisch S, Stuart P, Chia N, et al. The genetics of psoriasis 2001: the odyssey continues. Arch Dermatol. 2001;137(11):1447–54. Epub 2001/11/16.

    Article  CAS  PubMed  Google Scholar 

  11. International Psoriasis Genetics Consortium. The International Psoriasis Genetics Study: assessing linkage to 14 candidate susceptibility loci in a cohort of 942 affected sib pairs. American journal of human genetics. 2003;73(2):430–7. Epub 2003/07/10.

    Article  Google Scholar 

  12. Capon F, Trembath RC, Barker JN. An update on the genetics of psoriasis. Dermatol Clin. 2004;22(4):339–47, vii. Epub 2004/09/29.

    Article  CAS  PubMed  Google Scholar 

  13. Capon F, Helms C, Veal CD, Tillman D, Burden AD, Barker JN, et al. Genetic analysis of PSORS2 markers in a UK dataset supports the association between RAPTOR SNPs and familial psoriasis. J Med Genet. 2004;41(6):459–60. Epub 2004/06/03.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  14. Morar N, Bowcock AM, Harper JI, Cookson WO, Moffatt MF. Investigation of the chromosome 17q25 PSORS2 locus in atopic dermatitis. J Invest Dermatol. 2006;126(3):603–6. Epub 2005/12/24.

    Article  CAS  PubMed  Google Scholar 

  15. Bowcock AM, Krueger JG. Getting under the skin: the immunogenetics of psoriasis. Nat Rev Immunol. 2005;5(9):699–711. Epub 2005/09/03.

    Article  CAS  PubMed  Google Scholar 

  16. Kere J. Mapping and identifying genes for asthma and psoriasis. Philos Trans R Soc Lond B Biol Sci. 2005;360(1460):1551–61. Epub 2005/08/13.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  17. Goldminz AM, Au SC, Kim N, Gottlieb AB, Lizzul PF. NF-kappaB: an essential transcription factor in psoriasis. J Dermatol Sci. 2013;69(2):89–94. Epub 2012/12/12.

    Article  CAS  PubMed  Google Scholar 

  18. Lowes MA, Russell CB, Martin DA, Towne JE, Krueger JG. The IL-23/T17 pathogenic axis in psoriasis is amplified by keratinocyte responses. Trends Immunol. 2013;34(4):174–81. Epub 2013/01/08.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  19. Chang YC, Wu WM, Chen CH, Hu CF, Hsu LA. Association between P478S polymorphism of the filaggrin gene and risk of psoriasis in a Chinese population in Taiwan. Arch Dermatol Res. 2008;300(3):133–7. Epub 2008/01/15.

    Article  CAS  PubMed  Google Scholar 

  20. Weichenthal M, Ruether A, Schreiber S, Nair R, Voorhees JJ, Schwarz T, et al. Filaggrin R501X and 2282del4 mutations are not associated with chronic plaque-type psoriasis in a German cohort. J Invest Dermatol. 2007;127(6):1535–7. Epub 2007/03/24.

    Article  CAS  PubMed  Google Scholar 

  21. Giardina E, Paolillo N, Sinibaldi C, Novelli G. R501X and 2282del4 filaggrin mutations do not confer susceptibility to psoriasis and atopic dermatitis in Italian patients. Dermatology. 2008;216(1):83–4. Epub 2007/11/23.

    Article  PubMed  Google Scholar 

  22. Winge MC, Suneson J, Lysell J, Nikamo P, Lieden A, Nordenskjold M, et al. Lack of association between filaggrin gene mutations and onset of psoriasis in childhood. J Eur Acad Dermatol Venereol. 2013;27(1):e124–7. Epub 2011/12/21.

    Article  CAS  PubMed  Google Scholar 

  23. Hu Z, Xiong Z, Xu X, Li F, Lu L, Li W, et al. Loss-of-function mutations in filaggrin gene associate with psoriasis vulgaris in Chinese population. Hum Genet. 2012;131(7):1269–74. Epub 2012/03/13.

    Article  CAS  PubMed  Google Scholar 

  24. Zhao Y, Terron-Kwiatkowski A, Liao H, Lee SP, Allen MH, Hull PR, et al. Filaggrin null alleles are not associated with psoriasis. J Invest Dermatol. 2007;127(8):1878–82. Epub 2007/04/06.

    Article  CAS  PubMed  Google Scholar 

  25. Thyssen JP, Johansen JD, Carlsen BC, Linneberg A, Meldgaard M, Szecsi PB, et al. The filaggrin null genotypes R501X and 2282del4 seem not to be associated with psoriasis: results from general population study and meta-analysis. J Eur Acad Dermatol Venereol. 2012;26(6):782–4. Epub 2011/05/14.

    Article  CAS  PubMed  Google Scholar 

  26. Bernard BA, Asselineau D, Schaffar-Deshayes L, Darmon MY. Abnormal sequence of expression of differentiation markers in psoriatic epidermis: inversion of two steps in the differentiation program? J Invest Dermatol. 1988;90(6):801–5. Epub 1988/06/01.

    Article  CAS  PubMed  Google Scholar 

  27. Watanabe S, Wagatsuma K, Ichikawa E, Takahashi H. Abnormal distribution of epidermal protein antigens in psoriatic epidermis. J Dermatol. 1991;18(3):143–51. Epub 1991/03/01.

    CAS  PubMed  Google Scholar 

  28. Gerritsen MJ, Elbers ME, de Jong EM, van de Kerkhof PC. Recruitment of cycling epidermal cells and expression of filaggrin, involucrin and tenascin in the margin of the active psoriatic plaque, in the uninvolved skin of psoriatic patients and in the normal healthy skin. J Dermatol Sci. 1997;14(3):179–88. Epub 1997/03/01.

    Article  CAS  PubMed  Google Scholar 

  29. Kim BE, Howell MD, Guttman-Yassky E, Gilleaudeau PM, Cardinale IR, Boguniewicz M, et al. TNF-alpha downregulates filaggrin and loricrin through c-Jun N-terminal kinase: role for TNF-alpha antagonists to improve skin barrier. J Invest Dermatol. 2011;131(6):1272–9. Epub 2011/02/25.

    Article  CAS  PubMed  Google Scholar 

  30. Elias PM, Ahn SK, Denda M, Brown BE, Crumrine D, Kimutai LK, et al. Modulations in epidermal calcium regulate the expression of differentiation-specific markers. J Invest Dermatol. 2002;119(5):1128–36. Epub 2002/11/26.

    Article  CAS  PubMed  Google Scholar 

  31. Fischer M, William T, Helmbold P, Wohlrab J, Marsch W. Expression of epidermal N-methyl-D-aspartate receptors (NMDAR1) depends on formation of the granular layer–analysis in diseases with parakeratotic cornification. Arch Dermatol Res. 2004;296(4):157–62. Epub 2004/09/01.

    CAS  PubMed  Google Scholar 

  32. Kristensen M, Chu CQ, Eedy DJ, Feldmann M, Brennan FM, Breathnach SM. Localization of tumour necrosis factor-alpha (TNF-alpha) and its receptors in normal and psoriatic skin: epidermal cells express the 55-kD but not the 75-kD TNF receptor. Clin Exp Immunol. 1993;94(2):354–62. Epub 1993/11/01.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  33. Ettehadi P, Greaves MW, Wallach D, Aderka D, Camp RD. Elevated tumour necrosis factor-alpha (TNF-alpha) biological activity in psoriatic skin lesions. Clin Exp Immunol. 1994;96(1):146–51. Epub 1994/04/01.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  34. Hvid M, Johansen C, Deleuran B, Kemp K, Deleuran M, Vestergaard C. Regulation of caspase 14 expression in keratinocytes by inflammatory cytokines–a possible link between reduced skin barrier function and inflammation? Exp Dermatol. 2011;20(8):633–6. Epub 2011/05/05.

    Article  CAS  PubMed  Google Scholar 

  35. Gutowska-Owsiak D, Schaupp AL, Salimi M, Selvakumar TA, McPherson T, Taylor S, et al. IL-17 downregulates filaggrin and affects keratinocyte expression of genes associated with cellular adhesion. Exp Dermatol. 2012;21(2):104–10. Epub 2012/01/11.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Peter Jensen MD, PhD .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Jensen, P., Skov, L. (2014). Filaggrin in Psoriasis. In: Thyssen, J., Maibach, H. (eds) Filaggrin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-54379-1_26

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-54379-1_26

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-54378-4

  • Online ISBN: 978-3-642-54379-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics